Shin-Ichi Miyatake
Overview
Explore the profile of Shin-Ichi Miyatake including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
1890
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yoshimura K, Kawabata S, Kashiwagi H, Fukuo Y, Takeuchi K, Futamura G, et al.
Cells
. 2021 Dec;
10(12).
PMID: 34943904
Background: Boron neutron capture therapy (BNCT) is a nuclear reaction-based tumor cell-selective particle irradiation method. High-dose methotrexate and whole-brain radiation therapy (WBRT) are the recommended treatments for primary central nervous...
12.
Kashiwagi H, Kawabata S, Yoshimura K, Fukuo Y, Kanemitsu T, Takeuchi K, et al.
Invest New Drugs
. 2021 Nov;
40(2):255-264.
PMID: 34816337
Introduction Boron neutron capture therapy (BNCT) is a biologically targeted, cell-selective particle irradiation therapy that utilizes the nuclear capture reaction of boron and neutron. Recently, accelerator neutron generators have been...
13.
Tsuji Y, Nonoguchi N, Okuzaki D, Wada Y, Motooka D, Hirota Y, et al.
Sci Rep
. 2021 Nov;
11(1):22110.
PMID: 34764346
Radiation therapy is one of standard treatment for malignant glioma after surgery. The microenvironment after irradiation is considered not to be suitable for the survival of tumor cells (tumor bed...
14.
Kawabata S, Suzuki M, Hirose K, Tanaka H, Kato T, Goto H, et al.
Neurooncol Adv
. 2021 Jun;
3(1):vdab067.
PMID: 34151269
Background: Boron neutron capture therapy (BNCT) utilizes tumor-selective particle radiation. This study aimed to assess the safety and efficacy of accelerator-based BNCT (AB-BNCT) using a cyclotron-based neutron generator (BNCT 30)...
15.
Takai S, Wanibuchi M, Kawabata S, Takeuchi K, Sakurai Y, Suzuki M, et al.
Neuro Oncol
. 2021 May;
24(1):90-98.
PMID: 33984146
Background: High-grade meningioma (HGM) is difficult to treat, and recurrent HGM after radiotherapy has an especially poor prognosis. We retrospectively analyzed the cases of 44 consecutive patients with recurrent and...
16.
Fukuo Y, Hattori Y, Kawabata S, Kashiwagi H, Kanemitsu T, Takeuchi K, et al.
Biology (Basel)
. 2020 Dec;
9(12).
PMID: 33271972
Background: The development of effective boron compounds is a major area of research in the study of boron neutron capture therapy (BNCT). We created a novel boron compound, boronophenylalanine-amide alkyl...
17.
Miyatake S, Wanibuchi M, Hu N, Ono K
J Neurooncol
. 2020 Jul;
149(1):1-11.
PMID: 32676954
Background: Boron neutron capture therapy (BNCT) is tumor-selective particle radiation therapy that depends on the nuclear capture and fission reactions. These reactions occur when a non-radioactive boron isotope (B) is...
18.
Takeuchi K, Hattori Y, Kawabata S, Futamura G, Hiramatsu R, Wanibuchi M, et al.
Cells
. 2020 Jul;
9(6).
PMID: 32630612
Boron neutron capture therapy (BNCT) is a form of tumor-cell selective particle irradiation using low-energy neutron irradiation of boron-10 (B) to produce high-linear energy transfer (LET) alpha particles and recoiling...
19.
Furuse M, Kuwabara H, Ikeda N, Hattori Y, Ichikawa T, Kagawa N, et al.
BMC Cancer
. 2020 Apr;
20(1):277.
PMID: 32248797
Background: The prevalence of programmed death-ligand 1 (PD-L1) and PD-L2 expression on tumor cells and tumor-infiltrating immune cells in primary central nervous system lymphoma (PCNSL) remains unclear. In the present...
20.
Furuse M, Nonoguchi N, Yamada K, Shiga T, Combes J, Ikeda N, et al.
Radiat Oncol
. 2019 Feb;
14(1):28.
PMID: 30728041
Introduction: This systematic review aims to elucidate the diagnostic accuracy of radiological examinations to distinguish between brain radiation necrosis (BRN) and tumor progression (TP). Methods: We divided diagnostic approaches into...